Member Info for eddie2707

Tiptree I think you need to do some research if you are asking questions like that!

Coverage yesterday was huge for us!! Finally waking people up!!

Well said Gizzard, I see there morons on every board talking about a share they are not invested in...

How sad must your life be to want to even do that!

Oh look go through destitutes history and he sold, what a surprise he is now spouting rubbish!!!

Jog on Idiot!!

I’ve averaged up to .25 with 4.2m shares!!

Either way its good news! Seller on fumes or huger buyer loading up!

Defo a buy from Friday! Due a TR1 on that amount!

That’s really positive! As they mentioned Friday about getting volunteers for certain trials

There are some strange desperate people out there!

Real or fake? Tempted to say not true but you never know...

https://twitter.com/vanadiumhighs/status/1245980201680584704?s=21

Make your mind up Icartz thought it was 5p an hour ago?

Think that was a sell Pilgrim! Griffiths shares

No! Thanks

Well it is my only share in the blue so that must be a positive!

What a great interview he seemed very confident! The cough did make me laugh though!

Van I think posters forget you can go back and look at there history! Just bitter because he was bashing at 40p and could have made a load here!

Alwaysone you were here 5 days ago all over the placing! Only if you bought hey hahahaha

Run along now Joe Wicks is on!!

Well said Islandgirl! Always derisk and enjoy the free ride :)

Press release

Synairgen plc

('Synairgen' or the 'Company')

Synairgen confirms commencement of dosing in trial of SNG001 in COVID-19

Southampton, UK - 31 March 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces that it has now commenced dosing patients in its trial of SNG001 (inhaled formulation of interferon-beta-1a) in COVID-19 patients. This announcement follows the one made by the Company on 18 March 2020.

The first patient has been dosed at the initial trial site (University Hospital Southampton NHS Foundation Trust). Synairgen has initiated a further six trial sites which are expected to start dosing in the coming days.

Richard Marsden, CEO of Synairgen, commented: "We are delighted to get this trial underway with the dosing of the first patient. The team has worked tirelessly and intensively with the relevant authorities and collaborators to get to this stage, and we now look forward to recruiting more patients and completing the trial as soon as possible. A successful outcome from this trial in COVID-19 patients would be a very important step towards a major breakthrough in the fight against this coronavirus pandemic."

But but but it was meant to go down to 35p! Hahahaha can not hear you now!